These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 20386818
1. Chimeric microtubule disruptors. Leese MP, Jourdan F, Kimberley MR, Cozier GE, Thiyagarajan N, Stengel C, Regis-Lydi S, Foster PA, Newman SP, Acharya KR, Ferrandis E, Purohit A, Reed MJ, Potter BV. Chem Commun (Camb); 2010 May 07; 46(17):2907-9. PubMed ID: 20386818 [Abstract] [Full Text] [Related]
2. Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents. Leese MP, Jourdan FL, Gaukroger K, Mahon MF, Newman SP, Foster PA, Stengel C, Regis-Lydi S, Ferrandis E, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BV. J Med Chem; 2008 Mar 13; 51(5):1295-308. PubMed ID: 18260615 [Abstract] [Full Text] [Related]
3. 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. Leese MP, Leblond B, Smith A, Newman SP, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BV. J Med Chem; 2006 Dec 28; 49(26):7683-96. PubMed ID: 17181151 [Abstract] [Full Text] [Related]
4. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety. Ghorab MM, Ragab FA, Hamed MM. Eur J Med Chem; 2009 Oct 28; 44(10):4211-7. PubMed ID: 19540022 [Abstract] [Full Text] [Related]
5. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Di Fiore A, Pedone C, Antel J, Waldeck H, Witte A, Wurl M, Scozzafava A, Supuran CT, De Simone G. Bioorg Med Chem Lett; 2008 Apr 15; 18(8):2669-74. PubMed ID: 18359629 [Abstract] [Full Text] [Related]
6. Out of the active site binding pocket for carbonic anhydrase inhibitors. D'Ambrosio K, Carradori S, Monti SM, Buonanno M, Secci D, Vullo D, Supuran CT, De Simone G. Chem Commun (Camb); 2015 Apr 15; 51(2):302-5. PubMed ID: 25407638 [Abstract] [Full Text] [Related]
7. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II. Banerjee AL, Swanson M, Roy BC, Jia X, Haldar MK, Mallik S, Srivastava DK. J Am Chem Soc; 2004 Sep 08; 126(35):10875-83. PubMed ID: 15339172 [Abstract] [Full Text] [Related]
8. Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors. Scott AD, Phillips C, Alex A, Flocco M, Bent A, Randall A, O'Brien R, Damian L, Jones LH. ChemMedChem; 2009 Dec 08; 4(12):1985-9. PubMed ID: 19882701 [No Abstract] [Full Text] [Related]
13. Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex. Yenikaya C, Sari M, Bülbül M, Ilkimen H, Celik H, Büyükgüngör O. Bioorg Med Chem; 2010 Jan 15; 18(2):930-8. PubMed ID: 20006931 [Abstract] [Full Text] [Related]
14. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents. Agrawal VK, Bano S, Supuran CT, Khadikar PV. Eur J Med Chem; 2004 Jul 15; 39(7):593-600. PubMed ID: 15236839 [Abstract] [Full Text] [Related]